BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Rapamycin, rs4950928, PPARA, nitric oxide metabolic process, Pseudomonas infection)
Bookmark Forward

QuickView for tnfrsf17 protein human


Curated Studies

Most Correlated Studies

  1. L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
  2. L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
  3. L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
  4. L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
  5. L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Real-World Data on Therapies for Relapsed or Refractory Multiple Myeloma: Key Data from ASH 2023-A P…
  2. BCMA-directed therapy for early relapsed and/or refractory multiple myeloma.
  3. Impact of soluble BCMA and non-T-cell factors on refractoriness to BCMA-targeting T-cell engagers in…
  4. Correlation of immune fitness with response to teclistamab in relapsed/refractory multiple myeloma i…
  5. Clinical updates of B‑cell maturation antigen‑targeted therapy in multiple myeloma (MM) and relapsed…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Safety and Tolerability of BION-1301 in Adults With Relapsed or Refractory Multiple Myeloma (MM)
  2. B Cell Maturation Antigen Targeted CAR-T Cells in Treatment With Relapsed and Refractory Multiple My…
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.